Presenter: Aine Sheridan, RGN, PG DIp (she/her/hers) – St Vincents University Hospital
### she/her/hersAuthor: Elysia Alvarez, MD, MPH – University of California Davis
### @@@ Spunt Sheri, MD, BA – Stanford University ### 2102315###Co-Author######Stanford University###Co-Author: Spunt Sheri, MD, BA – Stanford University
### @@@ Frances Maguire, PhD (she/her/hers) – University of California Davis ### 2102316###Co-Author###Epidemiologist###University of California Davis###Co-Author: Frances Maguire, PhD (she/her/hers) – University of California Davis
### she/her/hers @@@ Marcio Malogolowkin, MD – University of California Davis ### 2102317###Co-Author######University of California Davis###Co-Author: Marcio Malogolowkin, MD – University of California Davis
### @@@ Renata Abrahao, MD, PhD, MSc (she/her/hers) – University of California ### 2102318###Co-Author###Physician-scientist###University of California###Co-Author: Renata Abrahao, MD, PhD, MSc (she/her/hers) – University of California
### she/her/hers @@@ Steve W. Thorpe, MD – Orthopedic Surgery, University of California Davis, Sacramento ### 2102319###Co-Author###Orthopaedic Surgical Oncologist###Orthopedic Surgery, University of California Davis, Sacramento###Co-Author: Steve W. Thorpe, MD – Orthopedic Surgery, University of California Davis, Sacramento
### @@@ Qian li, MS – University Of California Davis ### 2102320###Co-Author######University Of California Davis###Co-Author: Qian li, MS – University Of California Davis
### @@@ Lor Randall, MD – University of California Davis ### 2102321###Co-Author###Chair & Professor###University of California Davis###Co-Author: Lor Randall, MD – University of California Davis
### @@@ Janai Carr-Ascher, MD, PhD – University of California Davis ### 2102322###Co-Author######University of California Davis###Co-Author: Janai Carr-Ascher, MD, PhD – University of California Davis
### @@@ Theresa Keegan, PhD, MS – University of California Davis ### 2102323###Co-Author###Professor of Medicine###University of California Davis###Co-Author: Theresa Keegan, PhD, MS – University of California Davis
### Paper 49Co-Author: Jia Hu, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Meera Hameed, MD – Memorial Sloan Kettering Cancer Center ### 2102019###Co-Author###Chief of Service, Surgical Pathology###Memorial Sloan Kettering Cancer Center###Co-Author: Meera Hameed, MD – Memorial Sloan Kettering Cancer Center
### @@@ Narasimhan Agaram, MBBS – Memorial Sloan Kettering Cancer Center ### 2102020###Co-Author###Attending Pathologist###Memorial Sloan Kettering Cancer Center###Co-Author: Narasimhan Agaram, MBBS – Memorial Sloan Kettering Cancer Center
### @@@ Karissa Whiting, MS – Memorial Sloan Kettering Cancer Center ### 2102021###Co-Author######Memorial Sloan Kettering Cancer Center###Co-Author: Karissa Whiting, MS – Memorial Sloan Kettering Cancer Center
### @@@ Li-Xuan Qin, PhD (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2102022###Co-Author###Attending Biostatistician###Memorial Sloan Kettering Cancer Center###Co-Author: Li-Xuan Qin, PhD (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Anthony M. Villano, MD (he/him/his) – Fox Chase Cancer Center ### 2102023###Co-Author###Assistant Professor###Fox Chase Cancer Center###Co-Author: Anthony M. Villano, MD (he/him/his) – Fox Chase Cancer Center
### he/him/his @@@ Rachael O'Connor, BS – Memorial Sloan Kettering Cancer Center ### 2102024###Co-Author###Medical Technologist###Memorial Sloan Kettering Cancer Center###Co-Author: Rachael O'Connor, BS – Memorial Sloan Kettering Cancer Center
### @@@ Yuliy Rozenberg, PhD – Memorial Sloan Kettering Cancer Center ### 2102025###Co-Author######Memorial Sloan Kettering Cancer Center###Co-Author: Yuliy Rozenberg, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Sonia Cohen, MD – Memorial Sloan Kettering Cancer Center ### 2102026###Co-Author######Memorial Sloan Kettering Cancer Center###Co-Author: Sonia Cohen, MD – Memorial Sloan Kettering Cancer Center
### @@@ Katherine Prendergast, MD – Memorial Sloan Kettering Cancer Center ### 2102027###Co-Author######Memorial Sloan Kettering Cancer Center###Co-Author: Katherine Prendergast, MD – Memorial Sloan Kettering Cancer Center
### @@@ Richard White, MD – Atrium Health ### 2102028###Co-Author######Atrium Health###Co-Author: Richard White, MD – Atrium Health
### @@@ Mitchell Posner, MD – University of Chicago ### 2102029###Co-Author###Professor and Chief###University of Chicago###Co-Author: Mitchell Posner, MD – University of Chicago
### @@@ Nicholas Socci, PhD – Memorial Sloan Kettering Cancer Center ### 2102030###Co-Author######Memorial Sloan Kettering Cancer Center###Co-Author: Nicholas Socci, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Samuel Singer, MD, FACS – Memorial Sloan Kettering Cancer Center ### 2102031###Co-Author###Dr###Memorial Sloan Kettering Cancer Center###Co-Author: Samuel Singer, MD, FACS – Memorial Sloan Kettering Cancer Center
### @@@ Mrinal Gounder, MD – Memorial Sloan Kettering Cancer Center ### 2101875###Co-Author######Memorial Sloan Kettering Cancer Center###Co-Author: Mrinal Gounder, MD – Memorial Sloan Kettering Cancer Center
### @@@ Aimee M. Crago, MD, PhD, FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2102032###Author###Associate Attending Surgeon###Memorial Sloan Kettering Cancer Center###Author: Aimee M. Crago, MD, PhD, FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers Paper 41Author: Neeta Somaiah, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Michael C. Heinrich, MD – Portland VA Health Care System and Oregon Health & Science University Knight Cancer Institute ### 2101916###Co-Author###Professor of Medicine###Portland VA Health Care System and Oregon Health & Science University Knight Cancer Institute###Co-Author: Michael C. Heinrich, MD – Portland VA Health Care System and Oregon Health & Science University Knight Cancer Institute
### @@@ Jonathan Trent, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami ### 2101926###Co-Author###Professor of Medicine###Sylvester Comprehensive Cancer Center, University of Miami###Co-Author: Jonathan Trent, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami
### @@@ Breelyn A. Wilky, MD (she/her/hers) – University of Colorado Cancer Center ### 2101927###Co-Author###Associate Professor###University of Colorado Cancer Center###Co-Author: Breelyn A. Wilky, MD (she/her/hers) – University of Colorado Cancer Center
### she/her/hers @@@ Melissa A. Burgess, MD (she/her/hers) – University of Pittsburgh Medical Center Hillman Cancer Center ### 2101928###Co-Author###-###University of Pittsburgh Medical Center Hillman Cancer Center###Co-Author: Melissa A. Burgess, MD (she/her/hers) – University of Pittsburgh Medical Center Hillman Cancer Center
### she/her/hers @@@ Arun Singh, MD (he/him/his) – University of California Los Angeles ### 2101929###Co-Author###Associate Professor###University of California Los Angeles###Co-Author: Arun Singh, MD (he/him/his) – University of California Los Angeles
### he/him/his @@@ Steven Attia, D.O. – Mayo Clinic ### 2101930###Co-Author###Consultant###Mayo Clinic###Co-Author: Steven Attia, D.O. – Mayo Clinic
### @@@ Mark Agulnik, MD (he/him/his) – City of Hope, Department of Medical Oncology & Therapeutics Research ### 2101931###Co-Author###Sarcoma Section Chief###City of Hope, Department of Medical Oncology & Therapeutics Research###Co-Author: Mark Agulnik, MD (he/him/his) – City of Hope, Department of Medical Oncology & Therapeutics Research
### he/him/his @@@ William D. Tap, MD – Memorial Sloan Kettering Cancer Center ### 2101892###Co-Author###Chief, Sarcoma Medical Oncology###Memorial Sloan Kettering Cancer Center###Co-Author: William D. Tap, MD – Memorial Sloan Kettering Cancer Center
### @@@ Sebastian Bauer, MD (he/him/his) – Department of Medical Oncology, West German Cancer Center, University Hospital Essen ### 2101909###Co-Author###Attending, Director Sarcoma Center###Department of Medical Oncology, West German Cancer Center, University Hospital Essen###Co-Author: Sebastian Bauer, MD (he/him/his) – Department of Medical Oncology, West German Cancer Center, University Hospital Essen
### he/him/his @@@ Robin L. Jones, BSc, MB BS, MRCP, MD – Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research ### 2101847###Co-Author###Consultant Medical Oncologist###Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research###Co-Author: Robin L. Jones, BSc, MB BS, MRCP, MD – Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
### @@@ César Serrano, MD, PhD – Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain ### 2101911###Co-Author######Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain###Co-Author: César Serrano, MD, PhD – Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain
### @@@ Liangxing Zou, PhD – Cogent Biosciences ### 2101932###Co-Author######Cogent Biosciences###Co-Author: Liangxing Zou, PhD – Cogent Biosciences
### @@@ Kevin Moynihan – Cogent Biosciences ### 2101933###Co-Author###Director, Clinical Operations###Cogent Biosciences###Co-Author: Kevin Moynihan – Cogent Biosciences
### @@@ Julia Lawrence, DO – Cogent Biosciences ### 2101934###Co-Author###Senior Medical Director, Clinical Sciences###Cogent Biosciences###Co-Author: Julia Lawrence, DO – Cogent Biosciences
### @@@ Andrew J. Wagner, MD, PhD – Dana-Farber Cancer Institute ### 2101852###Co-Author###Associate Professor of Medicine###Dana-Farber Cancer Institute###Co-Author: Andrew J. Wagner, MD, PhD – Dana-Farber Cancer Institute
### Paper 62Author: Anthony R. Cillo, PhD (he/him/his) – University of Pittsburgh
### he/him/his @@@ Jessica Daley, MD – University of Pittsburgh ### 2101956###Co-Author###Instructor###University of Pittsburgh###Co-Author: Jessica Daley, MD – University of Pittsburgh
### @@@ Elina Mukherjee, MS – University of Pittsburgh ### 2101957###Co-Author######University of Pittsburgh###Co-Author: Elina Mukherjee, MS – University of Pittsburgh
### @@@ Anthony Green, unk – University of Pittsburgh ### 2101958###Co-Author######University of Pittsburgh###Co-Author: Anthony Green, unk – University of Pittsburgh
### @@@ Ernest Meyer – University of Pittsburgh ### 2101959###Co-Author###Research Scientist###University of Pittsburgh###Co-Author: Ernest Meyer – University of Pittsburgh
### @@@ Tullia Bruno, PhD – University of Pittsburgh ### 2101960###Co-Author######University of Pittsburgh###Co-Author: Tullia Bruno, PhD – University of Pittsburgh
### @@@ Hussein Tawbi, MD – MD Anderson ### 2101961###Co-Author######MD Anderson###Co-Author: Hussein Tawbi, MD – MD Anderson
### @@@ Melissa A. Burgess, MD (she/her/hers) – University of Pittsburgh Medical Center Hillman Cancer Center ### 2101928###Co-Author###-###University of Pittsburgh Medical Center Hillman Cancer Center###Co-Author: Melissa A. Burgess, MD (she/her/hers) – University of Pittsburgh Medical Center Hillman Cancer Center
### she/her/hers @@@ Kelly M. Bailey, MD, PhD – University of Pittsburgh School of Medicine ### 2101962###Co-Author###Assistant Professor of Pediatrics###University of Pittsburgh School of Medicine###Co-Author: Kelly M. Bailey, MD, PhD – University of Pittsburgh School of Medicine
### Paper 36Author: Suzanne Fischer, MD (she/her/hers) – Ghent University
### she/her/hers @@@ David Creytens, M.D. – Ghent University Hospital ### 2104857###Co-Author###Professor###Ghent University Hospital###Co-Author: David Creytens, M.D. – Ghent University Hospital
### @@@ Sofie De Geyter, Ms – Ghent University ### 2104858###Co-Author######Ghent University###Co-Author: Sofie De Geyter, Ms – Ghent University
### @@@ Stefanie Gijsels, MD (she/her/hers) – Ghent University ### 2104859###Co-Author###PhD candidate###Ghent University###Co-Author: Stefanie Gijsels, MD (she/her/hers) – Ghent University
### she/her/hers @@@ Elly De Vlieghere, dr. – Ghent University ### 1430205###Co-Author###dr.###Ghent University###Co-Author: Elly De Vlieghere, dr. – Ghent University
### @@@ Piet Pattyn, M.D. – Ghent University Hospital ### 2104860###Co-Author###Professor###Ghent University Hospital###Co-Author: Piet Pattyn, M.D. – Ghent University Hospital
### @@@ Sarah-Lee Beaert, ms – Ghent University ### 2104861###Co-Author######Ghent University###Co-Author: Sarah-Lee Beaert, ms – Ghent University
### @@@ Kaat Durinck, dr. – Ghent University ### 2104862###Co-Author###Professor###Ghent University###Co-Author: Kaat Durinck, dr. – Ghent University
### @@@ Nadine Van Roy, M.D. – Ghent University ### 2104863###Co-Author###Professor###Ghent University###Co-Author: Nadine Van Roy, M.D. – Ghent University
### @@@ An Hendrix, dr – Ghent University ### 1430207###Co-Author###Professor###Ghent University###Co-Author: An Hendrix, dr – Ghent University
### @@@ Lore Lapeire, M.D. – Ghent University Hospital ### 2104864###Co-Author###Professor###Ghent University Hospital###Co-Author: Lore Lapeire, M.D. – Ghent University Hospital
### @@@ Gwen ML Sys, MD, PhD (she/her/hers) – Ghent University Hospital ### 1430209### Co-Author###prof.###Ghent University Hospital###Co-Author: Gwen ML Sys, MD, PhD (she/her/hers) – Ghent University Hospital
### she/her/hers Paper 77Author: Nathan EL-GHAZZI, Resident (he/him/his) – Institut Bergonié INSERM BRIC U1312
### he/him/his @@@ Tony Sourisseau, PhD – Institut Bergonié INSERM BRIC U1312 ### 2102418###Co-Author######Institut Bergonié INSERM BRIC U1312###Co-Author: Tony Sourisseau, PhD – Institut Bergonié INSERM BRIC U1312
### @@@ Antoine Italiano, MD,PhD – Institut Bergonié ### 2101857###Co-Author######Institut Bergonié###Co-Author: Antoine Italiano, MD,PhD – Institut Bergonié
### Paper 73Author: Andy Livingston, MD, MS (he/him/his) – The University of Texas MD Anderson Cancer Center
### he/him/his @@@ Gregory M. Cote, MD, PhD (he/him/his) – Mass General Cancer Center ### 2102128###Co-Author###Assistant Professor###Mass General Cancer Center###Co-Author: Gregory M. Cote, MD, PhD (he/him/his) – Mass General Cancer Center
### he/him/his @@@ Jean-Yves Blay, MD, PhD – Centre Léon-Bérard ### 2101899###Co-Author###PUPH###Centre Léon-Bérard###Co-Author: Jean-Yves Blay, MD, PhD – Centre Léon-Bérard
### @@@ Jonathan Trent, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami ### 2101926###Co-Author###Professor of Medicine###Sylvester Comprehensive Cancer Center, University of Miami###Co-Author: Jonathan Trent, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami
### @@@ Claudia Valverde, MD – Vall D’Hebron University Hospital ### 2102262###Co-Author###Senior Consultant Medical Oncology Department###Vall D’Hebron University Hospital###Co-Author: Claudia Valverde, MD – Vall D’Hebron University Hospital
### @@@ Mark Agulnik, MD (he/him/his) – City of Hope, Department of Medical Oncology & Therapeutics Research ### 2101931###Co-Author###Sarcoma Section Chief###City of Hope, Department of Medical Oncology & Therapeutics Research###Co-Author: Mark Agulnik, MD (he/him/his) – City of Hope, Department of Medical Oncology & Therapeutics Research
### he/him/his @@@ Mrinal Gounder, MD – Memorial Sloan Kettering Cancer Center ### 2101875###Co-Author######Memorial Sloan Kettering Cancer Center###Co-Author: Mrinal Gounder, MD – Memorial Sloan Kettering Cancer Center
### @@@ Axel Le Cesne, MD – Gustave Roussy Institute ### 2101856###Co-Author######Gustave Roussy Institute###Co-Author: Axel Le Cesne, MD – Gustave Roussy Institute
### @@@ Meredith McKean, MPH, MD – Sarah Cannon Research Institute ### 2102263###Co-Author######Sarah Cannon Research Institute###Co-Author: Meredith McKean, MPH, MD – Sarah Cannon Research Institute
### @@@ Michael J. Wagner, MD – University of Washington/Fred Hutch/Seattle Cancer Care Alliance ### 2102264###Co-Author######University of Washington/Fred Hutch/Seattle Cancer Care Alliance###Co-Author: Michael J. Wagner, MD – University of Washington/Fred Hutch/Seattle Cancer Care Alliance
### @@@ Silvia Stacchiotti, MD (she/her/hers) – Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2102240###Co-Author###Consultant###Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Silvia Stacchiotti, MD (she/her/hers) – Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### she/her/hers @@@ Samuel V. Agresta, MD – Foghorn Therapeutics ### 2102265###Co-Author###Chief Medical Officer###Foghorn Therapeutics###Co-Author: Samuel V. Agresta, MD – Foghorn Therapeutics
### @@@ Sarah Reilly, MD, MPH – Foghorn Therapeutics ### 2102266###Co-Author###Senior Medical Director###Foghorn Therapeutics###Co-Author: Sarah Reilly, MD, MPH – Foghorn Therapeutics
### @@@ Kathleen Healy, n/a – Foghorn Therapeutics ### 2102267###Co-Author######Foghorn Therapeutics###Co-Author: Kathleen Healy, n/a – Foghorn Therapeutics
### @@@ Denice Hickman, Registered Nurse/BSN (she/her/hers) – Foghorn Therapeutics ### 2102268###Co-Author###Senior Director, Pharmacovigilance and Safety###Foghorn Therapeutics###Co-Author: Denice Hickman, Registered Nurse/BSN (she/her/hers) – Foghorn Therapeutics
### she/her/hers @@@ Mike Collins, PhD (he/him/his) – Foghorn Therapeutics ### 2102269###Co-Author###Senior Scientist, Translational Research###Foghorn Therapeutics###Co-Author: Mike Collins, PhD (he/him/his) – Foghorn Therapeutics
### he/him/his @@@ Scott Innis, MS – Foghorn Therapeutics ### 2102270###Co-Author###VP, Program Lead###Foghorn Therapeutics###Co-Author: Scott Innis, MS – Foghorn Therapeutics
### @@@ Alexandra R. Ballesteros-Perez, PhD (she/her/hers) – Certara ### 2102271###Co-Author###Associate Director, Clinical Pharmacologist###Certara###Co-Author: Alexandra R. Ballesteros-Perez, PhD (she/her/hers) – Certara
### she/her/hers @@@ Andrew J. Wagner, MD, PhD – Dana-Farber Cancer Institute ### 2101852###Co-Author###Associate Professor of Medicine###Dana-Farber Cancer Institute###Co-Author: Andrew J. Wagner, MD, PhD – Dana-Farber Cancer Institute
### Paper 25Author: Danny J. Indelicato, MD – University of Florida
### @@@ Alexandra Callan, MD – UT Southwestern Medical Center ### 2101982###Co-Author###Assistant Professor###UT Southwestern Medical Center###Co-Author: Alexandra Callan, MD – UT Southwestern Medical Center
### @@@ Safia K. Ahmed, MD – Mayo Clinic Arizona ### 2101983###Co-Author###Assistant Professor of Radiation Oncology###Mayo Clinic Arizona###Co-Author: Safia K. Ahmed, MD – Mayo Clinic Arizona
### @@@ Mark Krailo, PhD – University of Southern California ### 2101984###Co-Author###Professor###University of Southern California###Co-Author: Mark Krailo, PhD – University of Southern California
### @@@ Allen B. Buxton, MS (he/him/his) – Public Health Institute, Children's Oncology Group ### 2101985###Co-Author###Statistician###Public Health Institute, Children's Oncology Group###Co-Author: Allen B. Buxton, MS (he/him/his) – Public Health Institute, Children's Oncology Group
### he/him/his @@@ Odion Binitie, MD – H. Lee Moffitt Cancer Center ### 2101986###Co-Author###Associate Professor###H. Lee Moffitt Cancer Center###Co-Author: Odion Binitie, MD – H. Lee Moffitt Cancer Center
### @@@ Alexander B. Christ, MD – University of California Los Angeles ### 2101987###Co-Author###Assistant Professor in Residence###University of California Los Angeles###Co-Author: Alexander B. Christ, MD – University of California Los Angeles
### @@@ Paul J. Chuba, MD PhD – Ascension Webber Cancer Center ### 2101988###Co-Author###Medical Director for Radiation Oncology###Ascension Webber Cancer Center###Co-Author: Paul J. Chuba, MD PhD – Ascension Webber Cancer Center
### @@@ Helen R. Nadel, MD FRCPC – Lucile Packard Children’s Hospital at Stanford University ### 2101989###Co-Author###Clinical Professor of Radiology , Director of Pediatric Nuclear Medicine###Lucile Packard Children’s Hospital at Stanford University###Co-Author: Helen R. Nadel, MD FRCPC – Lucile Packard Children’s Hospital at Stanford University
### @@@ Bruce Pawel, MD – Children's Hospital Los Angeles ### 2101990###Co-Author###Chief, Anatomic Pathology###Children's Hospital Los Angeles###Co-Author: Bruce Pawel, MD – Children's Hospital Los Angeles
### @@@ Richard Gorlick, MD – The University of Texas MD Anderson Cancer Center ### 2101991###Co-Author###Professor###The University of Texas MD Anderson Cancer Center###Co-Author: Richard Gorlick, MD – The University of Texas MD Anderson Cancer Center
### @@@ Damon Reed, MD – Moffitt Cancer Center ### 2101992###Co-Author######Moffitt Cancer Center###Co-Author: Damon Reed, MD – Moffitt Cancer Center
### @@@ Steven G. Dubois, MD, MS – Dana-Farber/Boston Children’s Cancer and Blood Disorders Center ### 2101993###Co-Author###Associate Professor###Dana-Farber/Boston Children’s Cancer and Blood Disorders Center###Co-Author: Steven G. Dubois, MD, MS – Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
### @@@ Katherine A. Janeway, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center ### 2101994###Co-Author######Dana-Farber/Boston Children's Cancer and Blood Disorders Center###Co-Author: Katherine A. Janeway, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center
### @@@ Patrick Leavey, MD – UT-Southwestern ### 2101995###Co-Author######UT-Southwestern###Co-Author: Patrick Leavey, MD – UT-Southwestern
### @@@ Nadia Laack, MD, MS – Mayo Clinic ### 2101996###Co-Author###Professor###Mayo Clinic###Co-Author: Nadia Laack, MD, MS – Mayo Clinic
### Paper 18Author: David S. Shulman, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center
### @@@ Kelly Klega, MS, MLS(ASCP) – Dana-Farber Cancer Institute ### 2102345###Co-Author######Dana-Farber Cancer Institute###Co-Author: Kelly Klega, MS, MLS(ASCP) – Dana-Farber Cancer Institute
### @@@ Allen B. Buxton, MS (he/him/his) – Public Health Institute, Children's Oncology Group ### 2101985###Co-Author###Statistician###Public Health Institute, Children's Oncology Group###Co-Author: Allen B. Buxton, MS (he/him/his) – Public Health Institute, Children's Oncology Group
### he/him/his @@@ Mohammad Tanhaemami, MS – Dana-Farber Cancer Institute ### 2102346###Co-Author###Bioinformatics Analyst###Dana-Farber Cancer Institute###Co-Author: Mohammad Tanhaemami, MS – Dana-Farber Cancer Institute
### @@@ Victoria Bainer, n/a – Dana-Farber Cancer Institute ### 2102347###Co-Author######Dana-Farber Cancer Institute###Co-Author: Victoria Bainer, n/a – Dana-Farber Cancer Institute
### @@@ Carrie Cibulskis, n/a – The Broad Institute ### 2102348###Co-Author######The Broad Institute###Co-Author: Carrie Cibulskis, n/a – The Broad Institute
### @@@ Richard Gorlick, MD – The University of Texas MD Anderson Cancer Center ### 2101991###Co-Author###Professor###The University of Texas MD Anderson Cancer Center###Co-Author: Richard Gorlick, MD – The University of Texas MD Anderson Cancer Center
### @@@ Julia L. Glade Bender, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2102349###Co-Author###Member and Vice Chair for Clinical Research###Memorial Sloan Kettering Cancer Center###Co-Author: Julia L. Glade Bender, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Damon Reed, MD – Moffitt Cancer Center ### 2101992###Co-Author######Moffitt Cancer Center###Co-Author: Damon Reed, MD – Moffitt Cancer Center
### @@@ Katherine A. Janeway, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center ### 2101994###Co-Author######Dana-Farber/Boston Children's Cancer and Blood Disorders Center###Co-Author: Katherine A. Janeway, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center
### @@@ Mark Krailo, PhD – University of Southern California ### 2101984###Co-Author###Professor###University of Southern California###Co-Author: Mark Krailo, PhD – University of Southern California
### @@@ Steven G. Dubois, MD, MS – Dana-Farber/Boston Children’s Cancer and Blood Disorders Center ### 2101993###Co-Author###Associate Professor###Dana-Farber/Boston Children’s Cancer and Blood Disorders Center###Co-Author: Steven G. Dubois, MD, MS – Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
### @@@ Brian D. Crompton, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center ### 2102350###Co-Author###Co-Director for Research, Pediatric Solid Tumor Program Assistant Professor of Pediatrics, Harvard Medical School Associate Member, Broad Institute of Harvard and MIT Dana-Farber/Boston Children’s Cancer and Blood Disorders Center###Dana-Farber/Boston Children's Cancer and Blood Disorders Center###Co-Author: Brian D. Crompton, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center
### Paper 65Author: Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School
### he/him/his @@@ Dirk Strauss, MD – Royal Marsden NHS Foundation Trust ### 2101967###Co-Author###Surgical Oncologist###Royal Marsden NHS Foundation Trust###Co-Author: Dirk Strauss, MD – Royal Marsden NHS Foundation Trust
### @@@ Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2101980###Co-Author###Chief Sarcoma Service and Chair of the Department of Surgery###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### he/him/his @@@ Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada ### 2101979###Co-Author######Mount Sinai Hospital, Toronto, ON, Canada###Co-Author: Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada
### @@@ Marco Fiore, MD, FEBS, FACS – Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2102380###Co-Author###Attending Surgical Oncologist###Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Marco Fiore, MD, FEBS, FACS – Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### Paper 57Author: Yuen Bun Tam, MSc (he/him/his) – The Institute of Cancer Research
### he/him/his @@@ Kaan Low, PhD – The Institute of Cancer Research ### 2102224###Co-Author###Higher Scientific Officer###The Institute of Cancer Research###Co-Author: Kaan Low, PhD – The Institute of Cancer Research
### @@@ Jessica Burns, PhD – The Institute of Cancer Research ### 2102225###Co-Author######The Institute of Cancer Research###Co-Author: Jessica Burns, PhD – The Institute of Cancer Research
### @@@ Khin Thway, MD – The Royal Marsden NHS Foundation Trust ### 2102226###Co-Author######The Royal Marsden NHS Foundation Trust###Co-Author: Khin Thway, MD – The Royal Marsden NHS Foundation Trust
### @@@ Robin L. Jones, BSc, MB BS, MRCP, MD – Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research ### 2101847###Co-Author###Consultant Medical Oncologist###Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research###Co-Author: Robin L. Jones, BSc, MB BS, MRCP, MD – Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
### @@@ Paul Huang, PhD – The Institute of Cancer Research ### 2102227###Co-Author###Group Leader###The Institute of Cancer Research###Co-Author: Paul Huang, PhD – The Institute of Cancer Research
### Paper 48